An interrupted time series analysis of trends in opioid-related emergency department visits from pre-COVID-19 pandemic to pandemic, from the Canadian Hospitals Injury Reporting and Prevention Program.
COVID-19
Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP)
Emergency department visits
Fentanyl
Heroin
Interrupted time series analysis
Opioids
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
04 08 2023
04 08 2023
Historique:
received:
16
12
2022
accepted:
28
07
2023
medline:
7
8
2023
pubmed:
4
8
2023
entrez:
3
8
2023
Statut:
epublish
Résumé
Opioid-related emergency department (ED) visits in Canada increased during the COVID-19 pandemic, but how trends in volume and case severity changed from pre-pandemic times through the pandemic is not known. Trends in ED visits related to specific types of opioids also remain unclear. Our objective was to describe pre-pandemic trends and how they changed with the onset of COVID-19 and thereafter. Based on data from the Canadian Hospitals Injury Reporting and Prevention Program, we identified opioid-related ED visits and constructed a time series from March 12, 2018 through March 7, 2021-two pre-COVID periods and one COVID period. We used an interrupted time series (ITS) analysis to examine trends in volume and case severity. We compared medians and means of monthly counts and percentages of severe cases between the periods, by sex, age, and opioid type. Before the pandemic, there was an increasing trend in fentanyl-related visits for males, females and 25- to 64-year-olds, and a decreasing trend in heroin-related visits for males and 18- to 64-year-olds. Fentanyl-related visits for 18- to 24-year-olds showed an immediate increase at the start of the pandemic and a decreasing trend during the pandemic. Heroin-related visits for 12- to 17-year-olds had an immediate increase at the start of the pandemic; for 18- to 24-year-olds and 45- to 64-year-olds, the prior decreasing pre-pandemic trend ceased. For pooled opioid-related visits, no significant trend in the percentage of severe cases was observed throughout the entire study period. This study shows that an ITS approach in trend analysis is a valuable supplement to comparisons of before and after measures (with or without controlling seasonal effects). The findings provide evidence on how ED presentations for opioid use evolved in Canada from 2018 to 2021. The results can inform policies designed to reduce opioid-related harm in the context of a public health emergency.
Sections du résumé
BACKGROUND
Opioid-related emergency department (ED) visits in Canada increased during the COVID-19 pandemic, but how trends in volume and case severity changed from pre-pandemic times through the pandemic is not known. Trends in ED visits related to specific types of opioids also remain unclear. Our objective was to describe pre-pandemic trends and how they changed with the onset of COVID-19 and thereafter.
METHODS
Based on data from the Canadian Hospitals Injury Reporting and Prevention Program, we identified opioid-related ED visits and constructed a time series from March 12, 2018 through March 7, 2021-two pre-COVID periods and one COVID period. We used an interrupted time series (ITS) analysis to examine trends in volume and case severity. We compared medians and means of monthly counts and percentages of severe cases between the periods, by sex, age, and opioid type.
RESULTS
Before the pandemic, there was an increasing trend in fentanyl-related visits for males, females and 25- to 64-year-olds, and a decreasing trend in heroin-related visits for males and 18- to 64-year-olds. Fentanyl-related visits for 18- to 24-year-olds showed an immediate increase at the start of the pandemic and a decreasing trend during the pandemic. Heroin-related visits for 12- to 17-year-olds had an immediate increase at the start of the pandemic; for 18- to 24-year-olds and 45- to 64-year-olds, the prior decreasing pre-pandemic trend ceased. For pooled opioid-related visits, no significant trend in the percentage of severe cases was observed throughout the entire study period.
CONCLUSION
This study shows that an ITS approach in trend analysis is a valuable supplement to comparisons of before and after measures (with or without controlling seasonal effects). The findings provide evidence on how ED presentations for opioid use evolved in Canada from 2018 to 2021. The results can inform policies designed to reduce opioid-related harm in the context of a public health emergency.
Identifiants
pubmed: 37537534
doi: 10.1186/s12889-023-16414-z
pii: 10.1186/s12889-023-16414-z
pmc: PMC10401736
doi:
Substances chimiques
Analgesics, Opioid
0
Heroin
70D95007SX
Fentanyl
UF599785JZ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1483Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
J Addict Med. 2021 Jul-Aug 01;15(4):345-348
pubmed: 33870952
Drug Alcohol Depend. 2021 Nov 1;228:108977
pubmed: 34598100
Health Promot Chronic Dis Prev Can. 2020 Sep 11;40(11-12):336-341
pubmed: 32924925
J Subst Abuse Treat. 2021 Oct;129:108391
pubmed: 33994360
J Clin Pharm Ther. 2002 Aug;27(4):299-309
pubmed: 12174032
J Addict Dis. 2022 Jan-Mar;40(1):126-130
pubmed: 33955321
Pediatr Clin North Am. 2021 Oct;68(5):977-990
pubmed: 34538307
Accid Anal Prev. 2021 Jul;157:106195
pubmed: 34020183
Ann Emerg Med. 2022 Feb;79(2):158-167
pubmed: 34119326
JAMA Psychiatry. 2021 Apr 1;78(4):372-379
pubmed: 33533876
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
Ann Emerg Med. 2020 Oct;76(4):459-461
pubmed: 32747081
JAMA Netw Open. 2020 Dec 1;3(12):e2030676
pubmed: 33331915
Health Promot Chronic Dis Prev Can. 2016 Jun;36(6):112-7
pubmed: 27284703
PLoS One. 2022 Jan 13;17(1):e0262136
pubmed: 35025921